Previous close | 121.96 |
Open | 121.69 |
Bid | 119.01 x 800 |
Ask | 120.29 x 900 |
Day's range | 118.65 - 121.69 |
52-week range | 90.73 - 172.65 |
Volume | |
Avg. volume | 1,300,426 |
Market cap | 20.756B |
Beta (5Y monthly) | 1.05 |
PE ratio (TTM) | 86.55 |
EPS (TTM) | 1.38 |
Earnings date | 29 Jan 2024 |
Forward dividend & yield | 5.08 (4.17%) |
Ex-dividend date | 28 Dec 2023 |
1y target est | 131.58 |
High demand for Alexandria's (ARE) top-quality life science assets bodes well. Yet, a vast development outlay exposes it to the risk of rising construction costs amid high-interest rates.
In the realm of real estate investment trusts (REITs), insider transactions are closely monitored by investors seeking clues about a company's financial health and future prospects.
Investors may keep a tab on stocks like ARE, SUZ, GGG, COFS and LZB, which have lately hiked their dividend payments.